Product Catalog [{"id":"610","name":"Tizveni\/Tevimbra","price":0,"sku":"Tizveni (tislelizumab)","brand":false,"position":1,"category":"Medicines\/Oncology\/Lung Cancer"},{"id":"596","name":"Augtyro","price":0,"sku":"Augtyro (repotrectinib)","brand":"Bristol-Myers Squibb","position":2,"category":"Medicines\/Oncology\/Lung Cancer"},{"id":"554","name":"Krazati","price":31981.5,"sku":"Krazati (adagrasib)","brand":false,"position":3,"category":"Medicines\/Oncology\/Lung Cancer"},{"id":"527","name":"Vegzelma ","price":769.57,"sku":"Vegzelma (bevacizumab-adcd)","brand":"Celltrion Healthcare Hungary Kft","position":4,"category":"Medicines\/Oncology\/Lung Cancer"},{"id":"474","name":"Exkivity","price":30225,"sku":"Exkivity (mobocertinib)","brand":"Takeda Pharma A\/S","position":5,"category":"Medicines\/Oncology\/Lung Cancer"},{"id":"444","name":"Rybrevant","price":2230.41,"sku":"Rybrevant (amivantamab-vmjw)","brand":"Janssen Biotech","position":6,"category":"Medicines\/Oncology\/Lung Cancer"},{"id":"442","name":"Lumakras ","price":12392.91,"sku":"Lumakras (sotorasib)","brand":"Amgen Inc.","position":7,"category":"Medicines\/Oncology\/Lung Cancer"},{"id":"434","name":"Xalkori","price":4927.62,"sku":"Xalkori (crizotinib)","brand":"Pfizer Limited","position":8,"category":"Medicines\/Oncology\/Lung Cancer"},{"id":"420","name":"Cosela","price":2581.69,"sku":"Cosela (trilaciclib)","brand":"G1 Pharmaceuticals, Inc.","position":9,"category":"Medicines\/Oncology\/Lung Cancer"}]

Lung Cancer access options

Lung cancer, also known as lung carcinoma, is characterised by uncontrolled cell growth in tissues of the lung. The two main types are small-cell lung carcinoma (SCLC) and non-small-cell lung carcinoma (NSCLC). Non-small cell lung cancer (NSCLC) accounts for approximately 85% of all lung cancers. With an incidence of 1.8 million, lung cancer was the most common cancer worldwide in 2012, contributing 13% of the total number of new cases diagnosed. Treatment and long-term outcomes depend on the type of lung cancer, the stage (degree of spread), and the person’s overall health. Common lung cancer treatments include surgery, chemotherapy, and radiotherapy. NSCLC is sometimes treated with surgery,... Read more » whereas SCLC usually responds better to chemotherapy and radiotherapy.
  1. Tecentriq
    Tecentriq (Atezolizumab)
    Urothelial Carcinoma, Breast Cancer, Lung Cancer
    €7,452.90
  2. Tagrisso
    Tagrisso (osimertinib)
    Lung Cancer
    €8,458.03
  3. Portrazza
    Portrazza (necitumumab)
    Lung Cancer
    €9,241.93
  4. Opdivo
    Opdivo (Nivolumab)
    Urothelial Carcinoma, Colorectal Cancer, Head and Neck Cancer, Kidney Cancer, Liver Cancer, Lung Cancer, Lymphoma, Skin Cancer
    €867.24
  5. Keytruda
    Keytruda (pembrolizumab)
    Urothelial Carcinoma, Breast Cancer, Colorectal Cancer, Gastric Cancer, Head and Neck Cancer, Kidney Cancer, Lung Cancer, Lymphoma, Skin Cancer
    €4,225.50
  6. Imfinzi
    Imfinzi (durvalumab)
    Urothelial Carcinoma, Lung Cancer
    €1,052.33
  7. Alunbrig
    Alunbrig (brigatinib)
    Lung Cancer
    €1,199.66
  8. Alecensa
    Alecensa (alectinib)
    Lung Cancer
    €7,491.53
  9. Cyramza
    Cyramza (ramucirumab)
    Colorectal Cancer, Gastric Cancer, Lung Cancer
    €640.06
  10. Afinitor
    Afinitor (everolimus)
    Breast Cancer, Gastric Cancer, Kidney Cancer, Lung Cancer, Intestinal Cancer
    €4,614.81
  11. Vizimpro
    Vizimpro (dacomitinib)
    Lung Cancer
    €3,120.00
  12. Lorviqua
    Lorviqua (lorlatinib)
    Lung Cancer
    €4,656.03
View as Grid List

Items 1-12 of 27

Set Descending Direction
Read more about the latest treatments in Lung Cancer
US 0